This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Oct;56(10):3173-5.

doi: 10.1002/art.22926.

Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders

Shawn E Cowper, Phillip H Kuo, Richard Bucala

PMID: 17907160
DOI: 10.1002/art.22926

Editorial

Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders

Shawn E Cowper et al. Arthritis Rheum. 2007 Oct.

. 2007 Oct;56(10):3173-5.

doi: 10.1002/art.22926.

Authors

Shawn E Cowper, Phillip H Kuo, Richard Bucala

PMID: 17907160
DOI: 10.1002/art.22926

No abstract available

PubMed Disclaimer

Comment on

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Todd DJ, Kagan A, Chibnik LB, Kay J. Todd DJ, et al. Arthritis Rheum. 2007 Oct;56(10):3433-41. doi: 10.1002/art.22925. Arthritis Rheum. 2007. PMID: 17907148

Similar articles

Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Jamboti J. Jamboti J. Intern Med J. 2007 Jul;37(7):508-9; author reply 509. doi: 10.1111/j.1445-5994.2007.01413.x. Intern Med J. 2007. PMID: 17547734 No abstract available.
Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
Goveia M, Chan BP, Patel PR. Goveia M, et al. J Am Acad Dermatol. 2007 Oct;57(4):725-7. doi: 10.1016/j.jaad.2007.07.010. Epub 2007 Aug 8. J Am Acad Dermatol. 2007. PMID: 17689832 No abstract available.
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
Perazella MA, Rodby RA. Perazella MA, et al. Am J Med. 2007 Jul;120(7):561-2. doi: 10.1016/j.amjmed.2007.01.032. Am J Med. 2007. PMID: 17602923 No abstract available.
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K, Ezell LD, Macklin JG. Hamilton-Persaud K, et al. Nephrol Nurs J. 2007 May-Jun;34(3):283-7; quiz 288. Nephrol Nurs J. 2007. PMID: 17644872 Review.
Clinical and histological findings in nephrogenic systemic fibrosis.
Cowper SE, Rabach M, Girardi M. Cowper SE, et al. Eur J Radiol. 2008 May;66(2):191-9. doi: 10.1016/j.ejrad.2008.01.016. Epub 2008 Mar 5. Eur J Radiol. 2008. PMID: 18325705 Review.

See all similar articles

Cited by

Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.
Kanakia S, Toussaint J, Kukarni P, Lee S, Chowdhury SM, Khan S, Mallipattu SK, Shroyer KR, Moore W, Sitharaman B. Kanakia S, et al. Graphene Technol. 2016 Dec;1(1):17-28. doi: 10.1007/s41127-016-0001-2. Epub 2016 Aug 3. Graphene Technol. 2016. PMID: 28261636 Free PMC article.
Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation.
Vakil V, Sung JJ, Piecychna M, Crawford JR, Kuo P, Abu-Alfa AK, Cowper SE, Bucala R, Gomer RH. Vakil V, et al. J Magn Reson Imaging. 2009 Dec;30(6):1284-8. doi: 10.1002/jmri.21800. J Magn Reson Imaging. 2009. PMID: 19937928 Free PMC article.
Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.
Schroeder JA, Weingart C, Coras B, Hausser I, Reinhold S, Mack M, Seybold V, Vogt T, Banas B, Hofstaedter F, Krämer BK. Schroeder JA, et al. Clin J Am Soc Nephrol. 2008 Jul;3(4):968-75. doi: 10.2215/CJN.00100108. Epub 2008 Apr 2. Clin J Am Soc Nephrol. 2008. PMID: 18385397 Free PMC article.
Nephrogenic systemic fibrosis: current concepts.
Basak P, Jesmajian S. Basak P, et al. Indian J Dermatol. 2011 Jan;56(1):59-64. doi: 10.4103/0019-5154.77555. Indian J Dermatol. 2011. PMID: 21572795 Free PMC article.
Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.
Stollenwerk MM, Pashkunova-Martic I, Kremser C, Talasz H, Thurner GC, Abdelmoez AA, Wallnöfer EA, Helbok A, Neuhauser E, Klammsteiner N, Klimaschewski L, von Guggenberg E, Fröhlich E, Keppler B, Jaschke W, Debbage P. Stollenwerk MM, et al. Histochem Cell Biol. 2010 Apr;133(4):375-404. doi: 10.1007/s00418-010-0676-z. Epub 2010 Feb 20. Histochem Cell Biol. 2010. PMID: 20174817

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information